Fresenius SE

Welcome to Fresenius Investor Relations!

Here, you will find a wide range of facts and figures about Fresenius SE, its shares, current business development and corporate governance.

If you have any questions, just mail us at ir-fre@fresenius.de. We will be pleased to help.

Current News

17.07.2008Strong financial results in the first half of 2008 (preliminary figures)
PDF Text as PDF-file
17.07.2008Issuance of mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care AG & Co. KGaA
17.07.2008Fresenius SE successfully executes offering of € 554 million mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care
07.07.2008Fresenius Kabi to acquire APP Pharmaceuticals – entry into North American I.V. generics market provides excellent growth opportunities
20.05.2008Moody's upgrades rating of Fresenius SE to Ba1
PDF Text as PDF-file
30.04.2008Q1 2008: Successful start into 2008
(for additional tables please see pdf-file)
Home  >  Investor Relations